Gordian Biotechnology is introducing a method of screening hundreds of gene therapies simultaneously in an individual animal model - its co-founders explain
Francisco LePort and Martin Borch Jensen describe unpublished results unveiled today regarding the science behind the mosaic screening process that Gordian is using as a discovery platform focusing on aging related diseases.